|Icone Imprimer

Au sein du CNO Le 26 juin 2014

SIRIC ONCOLille - International Tumor Dormancy Symposium - June 26 2014, Lille, France

The Siric ONCOLille is pleased to announce the first Symposium on Tumor Dormancy which will take place in Lille, France, on June 26, 2014.

 

 

 

 

 Six internationally recognized leaders in the field will give seminars addressing various aspects of tumor dormancy, including micrometastasis, stem cell biology, angiogenesis, immunity, systems biology and minimal residual disease

  • Abstract deadline - March 31, 2014
  • Registration deadline - April 30, 2014

Scope of the meeting

Cancer relapses after a long - sometimes lasting for decades - period of dormancy. Understanding the mechanisms of equilibrium between patient predispositions and minimal residual disease has been challenging for years, but recent findings have led to considerable advances in uncovering the mechanisms that govern the long-term persistence of dormant cells and allow envisioning personal targeted therapy. The first ONCOLille Symposium will focus on the main fundamental and translational scientific approaches currently investigated in the tumor dormancy field.

We are pleased to welcome

  • Julio Aguirre-Ghiso, PhD, Division of Hematology and Oncology, Department of Medicine, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, USA,
  • Marieke Essers, PhD, Division of Stem Cells and Cancer, Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM), German Cancer Research Center (DKFZ) Heidelberg, Germany,
  • Stefano Indraccolo, PhD, Complex Operational Unit of Immunology and Oncological Molecular Diagnosis, Istituto Oncologico Veneto - IRCCS, Padua, Italy,
  • Martin Röcken, MD, Department of Dermatology, Eberhard Karls University, Tubingen, Germany
  • Philip Hahnfeldt, PhD, St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, USA,
  • Jean Soulier, MD PhD, Laboratoire Génome et Cancer, Institut National de la Santé et de la Recherche Médicale, Unité 944 and Service d’Hématologie Biologique, Hôpital Saint-Louis, Paris, France.

Organizing Committee

  • Bruno Quesnel, MD PhD, Service des Maladies du Sang, Hôpital Claude Huriez, CHRU de Lille, & Centre de Recherche Inserm 837, Institut pour la Recherche sur le Cancer de Lille (IRCL), Equipe "Facteurs de persistance des cellules leucémiques", Lille, France & ONCOLille Program 2 Coordinator,
  • Pierre Formstecher, MD PhD, Centre de Recherche Inserm 837, Institut pour la Recherche sur le Cancer de Lille (IRCL), Equipe "Ciblage moléculaire et cellulaire pour le traitement des cancers", Lille, France,
  • Corinne Abbadie, PhD, UMR8161 CNRS/Univ. Lille1/Univ. Lille2/Institut Pasteur de Lille, Institut de Biologie de Lille, France,
  • Xuefen Le Bourhis, PhD, Laboratoire de Signalisation des facteurs de croissance dans le cancer du sein, Protéomique fonctionnelle, Inserm U908, Villeneuve d’Ascq, France.
  • Renata Polakowska, PhD, Centre de Recherche Inserm 837, Institut pour la Recherche sur le Cancer de Lille (IRCL), Equipe "Ciblage moléculaire et cellulaire pour le traitement des cancers", Lille, France,
  • Natacha Prevarskaya, PhD, Laboratoire de Physiologie Cellulaire, Inserm U 1003, Villeneuve d’Ascq, France.

Program

Registration closed

Practical information

Venue - Travel - Accommodations

The symposium will take place at "Pôle Recherche", located square 8 on local access map.

Contact - Information - Registration

ONCOLille
Maison Régionale de la Recherche Clinique
6 rue du Professeur Laguesse
59037 Lille Cedex, France

Email: celine.coutte@chru-lille.fr

Office: +33 (0) 320 446 346 / Cell Phone: +33 (0) 659 510 886

 

More information about ONCOLille